Puma Biotechnology
PBYI
PBYI
139 hedge funds and large institutions have $442M invested in Puma Biotechnology in 2019 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 31 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 40
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
67% less capital invested
Capital invested by funds: $1.32B → $442M (-$882M)
Holders
139
Holding in Top 10
2
Calls
$5.05M
Puts
$2.88M
Top Buyers
| 1 | +$38M | |
| 2 | +$8.01M | |
| 3 | +$7.72M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.38M |
| 5 |
Morgan Stanley
New York
|
+$4.54M |
Top Sellers
| 1 | -$84.2M | |
| 2 | -$34.9M | |
| 3 | -$16.5M | |
| 4 |
O
OrbiMed
New York
|
-$16M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$10M |